The clinical significance of microvascular inflammation after kidney transplantation
2024-10-25
(Press-News.org)
San Diego, CA (October 24, 2024) — Investigators recently uncovered key insights into newly defined rejection entities in kidney transplantation that may offer improved patient risk categorization post-transplant. The research will be presented at ASN Kidney Week 2024 October 23– 27.
Kidney transplant rejection continues to threaten the long-term success of kidney transplants, with microvascular inflammation (inflammation within capillaries) playing a pivotal role in graft failure. Due to its complex nature, this inflammation poses a major challenge in clinical practice. In response, the international Banff classification—the global standard for diagnosing transplant rejection—has redefined antibody-mediated rejection diagnostics by introducing two new categories of microvascular inflammation: mild microvascular inflammation with probable antibody-mediated rejection and microvascular inflammation in the absence of antibody-mediated responses.
In a landmark study analyzing more than 16,000 biopsies from almost 7,000 kidney transplant recipients, researchers found that many cases initially considered as non-rejection were reclassified into the newly defined categories of microvascular inflammation. Importantly, reclassified patients with microvascular inflammation in the absence of antibody-mediated responses displayed an increased risk of graft failure compared with those without signs of rejection, underscoring the importance of this new classification.
“Recognizing these phenotypes could improve risk stratification and support more personalized management for kidney transplant patients,” explains first author, Aurélie Sannier, pathologist and researcher at the Paris Institute for Transplantation and Organ Regeneration. “We encourage large studies in other organ transplants where microvascular inflammation is also a critical feature of antibody-mediated rejection.”
Study: “Kidney Allograft Microvascular Inflammation Reveals Distinct Phenotypes and Outcomes: A Multinational Cohort Study”
Join ASN and approximately 12,000 other kidney professionals from across the globe at Kidney Week 2024 in San Diego, CA. The world's premier nephrology meeting, Kidney Week, provides participants with exciting and challenging opportunities to exchange knowledge, learn the latest scientific and medical advances, and listen to engaging and provocative discussions with leading experts in the field. Early programs begin on October 23, followed by the Annual Meeting from October 24-27. Follow the conversation at #KidneyWk.
About ASN
Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge and advocating for the highest quality care for patients. ASN has nearly 21,000 members representing 140 countries. For more information, visit www.asn-online.organd follow us on Facebook, X, LinkedIn, and Instagram.
# # #
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-10-24
**Embargo: 23.30 [UK time] / 06.30pm [US ET] Thursday 24th October 2024**
Peer reviewed / Literature review, systematic review and meta-analysis, opinion / People
Embargoed access to the Commission report and contact details for authors are available in Notes to Editors at the end of the release.
The Lancet Public Health: New Commission calls for regulatory reform to tackle the health impacts of the rapid global expansion of commercial gambling
Gambling harms are far more substantial than previously understood, exacerbated by rapid global expansion ...
2024-10-24
Barcelona, Spain: Researchers have shown that they can accurately re-create clinical trials of new treatments using ‘digital twins’ of real cancer patients. The technology, called FarrSight®-Twin, which is based on algorithms used by astrophysicists to discover black holes, will be presented today (Friday) at the 36th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain.
The researchers say that this approach could be used by cancer ...
2024-10-24
Barcelona, Spain: Researchers have shown for the first time that it is possible for a specially-designed ‘mini-protein’ to deliver a radiation dose directly to tumour cells expressing a protein on their cell surfaces called Nectin-4, which is often found in a number of different cancers.
In a study presented on Friday at the 36th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, Mike Sathekge, Professor and Head of the Nuclear Medicine Department at the University of Pretoria ...
2024-10-24
Barcelona, Spain: Patients with advanced bladder cancer that had spread to other parts of the body (metastasised) have responded well in a phase I clinical trial of an investigational drug, TYRA-300. The drug targets changes in the FGFR3 gene that drive tumour growth in about 10%-20% of these patients.
Associate Professor, Ben Tran, a medical oncologist at Peter McCallum Cancer Centre in Melbourne, Australia, presented the first results as of 15 August 2024 from 41 patients enrolled in the SURF301 study in a late-breaking oral presentation at the 36th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics ...
2024-10-24
Barcelona, Spain: Researchers have discovered key mutations in certain cancer cells that make them resistant to WRN inhibitors, a new class of anti-cancer drugs. The yet-to-be-published findings are presented on Friday at the 36th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain.
Werner helicase (WRN) inhibitors are already being evaluated in phase I clinical trials in patients with tumours that have microsatellite instability (MSI) – a condition in which the genes responsible for monitoring and repairing mistakes in DNA replication stop functioning, and errors are introduced. This is also ...
2024-10-24
PEMBROKE, N.H. — Approximately 71 to 95 million people in the Lower 48 states – more than 20% of the country’s population – may rely on groundwater that contains detectable concentrations of per- and polyfluoroalkyl substances, also known as PFAS, for their drinking water supplies. These findings are according to a U.S Geological Survey study published Oct. 24.
The predictive model results can help members of the public, water suppliers and regulators understand the potential for PFAS contamination, guide future studies and inform strategic planning for water resources.
USGS scientists are the first to ...
2024-10-24
New Zealand’s native stoneflies have changed colour in response to human-driven environmental changes, new research shows.
Just published in the journal Science, the University of Otago study provides arguably the world’s most clear-cut case of animal evolution in response to change made by humans.
Co-author Professor Jon Waters, of the Department of Zoology, says the stonefly has become a different colour due to recent deforestation.
“In natural forested regions, a native species has evolved ‘warning’ colours that mimic those of a poisonous forest species, to trick predators into ...
2024-10-24
As renewable energy sources such as wind and solar become more widespread, managing the power grid has become increasingly complex. Researchers at the University of Virginia have developed an innovative solution: an artificial intelligence model that can address the uncertainties of renewable energy generation and electric vehicle demand, making power grids more reliable and efficient.
Multi-Fidelity Graph Neural Networks: A New AI Solution
The new model is based on multi-fidelity graph neural networks (GNNs), ...
2024-10-24
One in five children has an identified mental health problem as early as age 3. Early detection is key to earlier intervention, and it also could prevent more severe conditions down the line, such as ADHD, depression and anxiety. Pediatric primary care is an ideal setting to conduct screening for mental health risk, given that pediatricians tend to have close, ongoing relationships with young patients and their families, and broad reach to historically marginalized communities. Since mental health screening of toddlers in primary care is uncommon, it is important to train pediatricians to do so without implicit bias and in a way that prevents unintended ...
2024-10-24
EL PASO, Texas (Oct. 24, 2024) – Researchers at The University of Texas at El Paso have created a portable device that can detect colorectal and prostate cancer more cheaply and quickly than prevailing methods. The team believes the device may be especially helpful in developing countries, which experience higher cancer mortality rates due in part to barriers to medical diagnosis.
“Our new biochip device is low-cost — just a few dollars — and sensitive, which will make accurate disease diagnosis accessible to anyone, ...
LAST 30 PRESS RELEASES:
[Press-News.org] The clinical significance of microvascular inflammation after kidney transplantation
